These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39120976)

  • 1. Protocol for transplantation of cells derived from human midbrain organoids into a Parkinson's disease mouse model to restore motor function.
    Fu CL; Jiang X; Dong BC; Li D; She XY; Yao J
    STAR Protoc; 2024 Sep; 5(3):103251. PubMed ID: 39120976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A robust protocol for the generation of human midbrain organoids.
    Zagare A; Gobin M; Monzel AS; Schwamborn JC
    STAR Protoc; 2021 Jun; 2(2):100524. PubMed ID: 34027482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells.
    Sarrafha L; Parfitt GM; Reyes R; Goldman C; Coccia E; Kareva T; Ahfeldt T
    STAR Protoc; 2021 Jun; 2(2):100463. PubMed ID: 33997803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
    Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
    Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
    [No Abstract]   [Full Text] [Related]  

  • 6. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.
    Nickels SL; Modamio J; Mendes-Pinheiro B; Monzel AS; Betsou F; Schwamborn JC
    Stem Cell Res; 2020 Jul; 46():101870. PubMed ID: 32534166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.
    Monzel AS; Smits LM; Hemmer K; Hachi S; Moreno EL; van Wuellen T; Jarazo J; Walter J; Brüggemann I; Boussaad I; Berger E; Fleming RMT; Bolognin S; Schwamborn JC
    Stem Cell Reports; 2017 May; 8(5):1144-1154. PubMed ID: 28416282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Evaluation of Parkinson's Disease Patient-Derived Midbrain Organoids Using Mesoporous Au Nanodot-Patterned 3D Concave Electrode.
    An J; Shin M; Beak G; Yoon J; Kim S; Cho HY; Choi JW
    ACS Sens; 2024 Jul; 9(7):3573-3580. PubMed ID: 38954790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells.
    Kim MS; Kim H; Lee G
    Adv Healthc Mater; 2024 Aug; 13(21):e2303041. PubMed ID: 38269602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon Fibers as a New Type of Scaffold for Midbrain Organoid Development.
    Tejchman A; Znój A; Chlebanowska P; Frączek-Szczypta A; Majka M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids.
    Kim H; Park HJ; Choi H; Chang Y; Park H; Shin J; Kim J; Lengner CJ; Lee YK; Kim J
    Stem Cell Reports; 2019 Mar; 12(3):518-531. PubMed ID: 30799274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
    Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson's disease mouse model.
    Fu CL; Dong BC; Jiang X; Li D; Yao J
    Heliyon; 2024 Jan; 10(2):e24234. PubMed ID: 38293351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
    Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for the generation of cultured cortical brain organoid slices.
    Petersilie L; Kafitz KW; Neu LA; Heiduschka S; Le S; Prigione A; Rose CR
    STAR Protoc; 2024 Sep; 5(3):103212. PubMed ID: 39128007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for human brain organoid transplantation into a rat visual cortex to model neural repair.
    Jgamadze D; Harary PM; Castellanos M; Blue R; Song H; Ming GL; Chen HI
    STAR Protoc; 2023 Sep; 4(3):102470. PubMed ID: 37585295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screening.
    Zanetti C; Spitz S; Berger E; Bolognin S; Smits LM; Crepaz P; Rothbauer M; Rosser JM; Marchetti-Deschmann M; Schwamborn JC; Ertl P
    Analyst; 2021 Apr; 146(7):2358-2367. PubMed ID: 33625407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
    Kriks S; Shim JW; Piao J; Ganat YM; Wakeman DR; Xie Z; Carrillo-Reid L; Auyeung G; Antonacci C; Buch A; Yang L; Beal MF; Surmeier DJ; Kordower JH; Tabar V; Studer L
    Nature; 2011 Nov; 480(7378):547-51. PubMed ID: 22056989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors.
    Oudin A; Baus V; Barthelemy V; Fabian C; Klein E; Dieterle M; Wantz M; Hau AC; Dording C; Bernard A; Michelucci A; Yabo YA; Kanli G; Keunen O; Bjerkvig R; Niclou SP; Golebiewska A
    STAR Protoc; 2021 Jun; 2(2):100534. PubMed ID: 34027491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.